ALCAFTADINE
Generic: ALCAFTADINE
Alembic Pharmaceuticals Inc.Manufacturer
OPHTHALMICRoute
ALCAFTADINEActive Substance
2024-10-02Original Approval
ALCAFTADINE is FDA application ANDA209290, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
2 reports
2
ABDOMINAL PAIN
1 reports
3
ACTIVITIES OF DAILY LIVING IMPAIRED
1 reports
4
AGITATION
1 reports
5
CONDITION AGGRAVATED
1 reports
6
DEATH
1 reports
7
DERMATITIS
1 reports
8
DRUG DOSE OMISSION
1 reports
9
DRY EYE
1 reports
10
EPILEPSY
1 reports